Literature DB >> 21961922

Granulomatous hepatitis, choroiditis and aortoduodenal fistula complicating intravesical Bacillus Calmette-Guérin therapy: Case report.

Cindy Q Gao1, Rozina Mithani, Jack Leya, Lesley Dawravoo, Arvin Bhatia, John Antoine, Felipe De Alba, Peter A Russo, Claus J Fimmel.   

Abstract

BACKGROUND: Intravesical instillation of Bacillus Calmette-Guérin (BCG) is the treatment of choice for superficial bladder carcinoma. Complications of BCG therapy include local infections and disseminated BCG infection with multiple endorgan complications. CASE
PRESENTATION: We report a case of disseminated, post-treatment BCG infection that initially presented with granulomatous hepatitis and choroiditis. After successful anti-mycobacterial therapy and resolution of the hepatic and ocular abnormalities, the patient developed an acute upper gastrointestinal hemorrhage from an aortoduodenal fistula that required emergency surgery. The resection specimen revealed multifocal, non-caseating granulomas, indicating mycobacterial involvement.
CONCLUSIONS: This case highlights the varied end organ complications of disseminated BCG infection, and the need for vigilance even in immuno-competent patients with a history of intravesical BCG treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21961922      PMCID: PMC3193172          DOI: 10.1186/1471-2334-11-260

Source DB:  PubMed          Journal:  BMC Infect Dis        ISSN: 1471-2334            Impact factor:   3.090


  12 in total

1.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-1998. A 57-year-old man with fever and jaundice after intravesical instillation of bacille Calmette-Guérin for bladder cancer.

Authors: 
Journal:  N Engl J Med       Date:  1998-09-17       Impact factor: 91.245

Review 2.  Primary aortoduodenal fistula in a patient with a history of intravesical therapy for bladder cancer with bacillus Calmette-Guérin: review of primary aortoduodenal fistula without abdominal aortic aneurysm.

Authors:  A Farber; V Grigoryants; D M Palac; T Chapman; J L Cronenwett; R J Powell
Journal:  J Vasc Surg       Date:  2001-04       Impact factor: 4.268

3.  Adverse drug reactions of intravesical bacillus Calmette-Guerin instillation and risk factors of the development of adverse drug reactions in superficial cancer and carcinoma in situ of the bladder.

Authors:  Hirofumi Koga; Masao Kuroda; Seiji Kudo; Akito Yamaguchi; Michiyuki Usami; Tadashi Suzuki; Seiji Naito
Journal:  Int J Urol       Date:  2005-02       Impact factor: 3.369

4.  Multiple mycotic aneurysms due to Mycobacterium bovis after intravesical bacillus Calmette-Guérin therapy.

Authors:  Raphael Coscas; Jean-Benoît Arlet; Denis Belhomme; Jean-Noël Fabiani; Jacques Pouchot
Journal:  J Vasc Surg       Date:  2009-08-05       Impact factor: 4.268

5.  Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma.

Authors:  Yan Guex-Crosier; Line Chamot; Léonidas Zografos
Journal:  Klin Monbl Augenheilkd       Date:  2003-03       Impact factor: 0.700

6.  Granulomatous hepatitis caused by Bacillus Calmette-Guerin (BCG) infection after BCG bladder instillation.

Authors:  F W Leebeek; R J Ouwendijk; A H Kolk; A Dees; J C Meek; J E Nienhuis; A M Dingemans-Dumas
Journal:  Gut       Date:  1996-04       Impact factor: 23.059

7.  Antibiotic and steroid therapy of massive systemic bacillus Calmette-Guerin toxicity.

Authors:  J I DeHaven; C Traynellis; D R Riggs; E Ting; D L Lamm
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

8.  Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer.

Authors:  D L Lamm; P M van der Meijden; A Morales; S A Brosman; W J Catalona; H W Herr; M S Soloway; A Steg; F M Debruyne
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma.

Authors:  D D Proctor; S Chopra; S C Rubenstein; J A Jokela; L Uhl
Journal:  Am J Gastroenterol       Date:  1993-07       Impact factor: 10.864

10.  Uveitis in a patient treated with Bacille-Calmette-Guérin: possible antigenic mimicry of mycobacterial and retinal antigens.

Authors:  Aylin Garip; Maria Diedrichs-Möhring; Stephan R Thurau; Cornelia A Deeg; Gerhild Wildner
Journal:  Ophthalmology       Date:  2009-10-07       Impact factor: 12.079

View more
  7 in total

1.  Bilateral symmetrical corneal melting following intravesical Bacille Calmette-Guerin therapy for bladder carcinoma.

Authors:  Chandana Chakraborty; Kumaresh C Sarkar; Swati Majumdar; Krittika P Chaudhury
Journal:  Oman J Ophthalmol       Date:  2012-05

2.  Bacillus Calmette-Guerin cystitis after intravesical therapy.

Authors:  I Gerogianni; I Neonakis; E Petinaki
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

3.  Aorto-enteric fistula development secondary to mycotic abdominal aortic aneurysm following intravesical bacillus Calmette-Guerin (BCG) treatment for transitional cell carcinoma of the bladder.

Authors:  Anthony Roylance; John Mosley; Mohideen Jameel; Axel Sylvan; Virginie Walker
Journal:  Int J Surg Case Rep       Date:  2012-10-05

Review 4.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Mycotic infrarenal aortic aneurysm due to mycobacterium after intravesical treatment for bladder cancer.

Authors:  Steve Thanh D Pham; Ashton Lee; Janin S Struminger; Kenneth M Belkoff; Bernardo Mendoza; Scott S Berman
Journal:  J Vasc Surg Cases Innov Tech       Date:  2021-03-02

6.  The Epithelial to Mesenchymal Transition Related Gene Calumenin Is an Adverse Prognostic Factor of Bladder Cancer Correlated With Tumor Microenvironment Remodeling, Gene Mutation, and Ferroptosis.

Authors:  YiHeng Du; WenHao Miao; Xiang Jiang; Jin Cao; Bo Wang; Yi Wang; Jiang Yu; XiZhi Wang; HaiTao Liu
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

7.  Acute Hepatitis Induced by Intravesical BCG Therapy: A Rare but Serious Complication.

Authors:  Hakima Abid; Mouna Figuigui; Sidi Adil Ibrahimi; Mohamed El Abkari; Mohamed Mzyiene; Soufiane Ennaciri; Ouima Justin Ziba; Mohamed Jamal El Fassi; Layla Tahiri Elousrouti; Laila Chbani
Journal:  Case Reports Hepatol       Date:  2021-06-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.